← Leaderboards
John S Chant
G1 Therapeutics, Inc.
$692,326
Attributed
$692,326
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $347.5K · FY2009–10$500K$375K$250K$125K$0
'09
'10
Funding mix
By agency
NIH$692,326 · 1
By mechanism
R43$692,326 · 1
Top collaborators
No co-investigators on record.
Most similar at G1 Therapeutics, Inc.
Same institution · by research overlap
- Jay Copeland Strum$3,647,891
- Patrick Joseph Roberts$647,891
Others in their field
Top investigators on “American”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Ethan Schreier · Associated Universities, Inc.$207,732,557
Research focus
AmericanAnimalsApoptoticAttenuatedBioavailableBloodBlood PlateletsBone MarrowBone Marrow CellsCell CycleCell Cycle ArrestCellsCell SurvivalChronicCyclin-Dependent Kinase 4Cyclin-Dependent Kinase InhibitorCyclin-Dependent KinasesDna DamageDna RepairDoseDrug CandidateDrug KineticsErythrocytesAcute